Tendarix.ca
The Department of National Defence (DND), specifically the Canadian Forces Health Services
(CFHS), has a requirement for the services of a Contractor to test and evaluate the feasibility of
manufacturing HI-6 DMS and atropine sulfate drug products in a reconstitution autoinjector device
(RAD).
The scope of this requirement is to conduct a feasibility assessment using an existing prototype
of a RAD with the configuration of HI-6 DMS in the dry chamber (500 mg +/- 25%) and 1 mL
atropine (2 mg/mL) in the liquid chamber.
The work will involve the following:
The buyer plans to award this contract to a named supplier without competition. If your business can do this work, send a statement of capabilities to the contracting authority before June 16, 2026. If it qualifies, the buyer must open a full competition.
Get a plain-English breakdown of this tender — what they need, who can bid, how to approach it, and tips for small suppliers. Takes a couple of seconds.
0 past awards in this classification and 5 likely incumbents from this buyer. Pro shows who won and for how much.
Upgrade to Pro